Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer

References

• Yuan M, Huang LL, Chen JH, et al. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct. Target Ther. 2019;4(1):1–14.
   PubMedGoogle Scholar
• Sebastian M, Reck M, Waller CF, et al. The efficacy and safety of BI 2536, a novel plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trial. J Thorac Oncol. 2010;5(7):1060–1067.
   PubMed Web of Science ®Google Scholar
• Chen R, Manochakian R, James L, et al. Emerging therapeutic agents for advanced non-small cell lung cancer. J Hematol Oncol. 2020;13(1):1–23.
   PubMed Web of Science ®Google Scholar
• Hsu WH, Yang JH, Mok TS, et al. Overview of current systemic management of EGFR-mutant NSCLC. Ann Oncol. 2018;29(suppl_1):i3–i9.
   PubMed Web of Science ®Google Scholar
• Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers. 2017;9(5):52.
   PubMed Web of Science ®Google Scholar
• Bethune G, Bethune D, Ridgway N, et al. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J. Thorac. Dis. 2010;2(1):48–51.
   PubMedGoogle Scholar
• Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358(11):1160–1174.
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Kono K, Mimura K, et al. Cetuximab induce antibody‐dependent cellular cytotoxicity against EGFR‐expressing esophageal squamous cell carcinoma. Int J Cancer. 2007;120(4):781–787.
   PubMed Web of Science ®Google Scholar
• Correale P, Botta C, Cusi MG, et al. Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of Colon cancer cells and ignites a highly efficient Colon cancer antigen-specific cytotoxic T-cell response in vitro. Int J Cancer. 2012;130(7):1577–1589.
   PubMed Web of Science ®Google Scholar
• Sunada H, Magun BE, Mendelsohn J, et al. Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc Natl Acad Sci U S A. 1986;83(11):3825–3829.
   PubMed Web of Science ®Google Scholar
• Jaramillo ML, Leon Z, Grothe S, et al. Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting. Exp Cell Res. 2006;312(15):2778–2790.
   PubMed Web of Science ®Google Scholar
• Sunada H, Yu P, Peacock JS, et al. Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody. J Cell Physiol. 1990;142(2):284–292.
   PubMed Web of Science ®Google Scholar
• Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res. Lett. 2021;16(1):1–21.
   PubMed Web of Science ®Google Scholar
• Patel J, Amrutiya J, Bhatt P, et al. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells. J Microencapsul. 2018;35(2):204–217.
   PubMed Web of Science ®Google Scholar
• Viswanadh MK, Jha A, Reddy Adena SK, et al. Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy. Nanomedicine (Lond). 2020;15(24):2345–2367.
   PubMed Web of Science ®Google Scholar
• Paul P, Sengupta S, Mukherjee B, et al. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice. Nanomedicine (Lond). 2018;13(5):501–520.
   PubMed Web of Science ®Google Scholar
• Mandal D, Shaw TK, Dey G, et al. Preferential hepatic uptake of paclitaxel-loaded poly-(DL-lactide-co-glycolide) nanoparticles—a possibility for hepatic drug targeting: pharmacokinetics and biodistribution. Int J Biol Macromol. 2018;112:818–830.
   PubMed Web of Science ®Google Scholar
• Mondal L, Mukherjee B, Das K, et al. CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice. Int J Nanomedicine. 2019;14:8073–8094.
   PubMed Web of Science ®Google Scholar
• Ehsan I, Kumari L, Sen R, et al. J591 functionalized paclitaxel loaded PLGA nanoparticles successfully inhibited PSMA overexpressing LNCaP cells. J. Drug Deliv. Sci. Technol. 2022;75:103689.
   Web of Science ®Google Scholar
• Aggarwal S, Gupta S, Pabla D, et al. Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer. Cancer Nanotechnol. 2013;4(6):145–157.
   PubMedGoogle Scholar
• Bhattacharya S, Mondal L, Mukherjee B, et al. Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats. Nanomedicine. 2018;14(6):1905–1917.
   PubMed Web of Science ®Google Scholar
• Dutta D, Paul B, Mukherjee B, et al. Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo. Sci Rep. 2019;9(1):1–20.
   PubMedGoogle Scholar
• Alfieri RR, Galetti M, Tramonti S, et al. Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines. Mol Cancer. 2011;10(1):143.
   PubMedGoogle Scholar
• Patel D, Lahiji A, Patel S, et al. Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface. Anticancer Res. 2007;27(5A):3355–3366.
   PubMed Web of Science ®Google Scholar
• Eble JA. Titration ELISA as a method to determine the dissociation constant of receptor ligand interaction. J Vis. Exp. 2018;132:e57334.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Dlie ZY, Mukherjee B, et al. A comparative investigation of the ability of various aptamer-Functionalized drug nanocarriers to induce selective apoptosis in neoplastic hepatocytes: in vitro and in vivo outcome. AAPS PharmSciTech. 2020;21(3):1–13.
   Web of Science ®Google Scholar
• Shahrad S, Rajabi M, Javadi H, et al. Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers. Sci Rep. 2022;12(1):1–11.
   PubMed Web of Science ®Google Scholar
• Townsend MH, Anderson MD, Weagel EG, et al. Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane. Onco Targets Ther. 2017;10:1921–1932.
   PubMed Web of Science ®Google Scholar
• Nandi D, Besra SE, Vedasiromoni JR, et al. Anti-leukemic activity of Wattakaka volubilis leaf extract against human myeloid leukemia cell lines. J Ethnopharmacol. 2012;144(3):466–473.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Dlie ZY, Chakraborty S, et al. Aptamer-functionalized drug nanocarrier improves ­hepatocellular carcinoma toward normal by targeting neoplastic hepatocytes. Mol Ther Nucleic Acids. 2020;20:34–49.
   PubMedGoogle Scholar
• Maya S, Sarmento B, Lakshmanan VK, et al. Chitosan cross-linked docetaxel loaded EGF receptor targeted nanoparticles for lung cancer cells. Int J Biol Macromol. 2014;69:532–541.
   PubMed Web of Science ®Google Scholar
• Wang Y, Guo M, Lin D, et al. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo. Drug Deliv. 2021;28(1):1510–1523.
   PubMed Web of Science ®Google Scholar
• Gaonkar RH, Ganguly S, Dewanjee S, et al. Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies. Sci Rep. 2017;7(1):1–14.
   PubMedGoogle Scholar
• Liu K, Chen W, Yang T, et al. Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery. Int J Nanomedicine. 2017;12:8239–8255.
   PubMed Web of Science ®Google Scholar
• Tang X, Wang G, Shi R, et al. Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles. Drug Deliv. 2016;23(8):2686–2696.
   PubMed Web of Science ®Google Scholar
• Qu N, Sun Y, Li Y, et al. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation. BioMed Eng OnLine. 2019;18(1):1–14.
   PubMedGoogle Scholar
• Choudhury P, Barua A, Roy A, et al. Eugenol emerges as an elixir by targeting β-catenin, the central cancer stem cell regulator in lung carcinogenesis: an in vivo and in vitro rationale. Food Funct. 2021;12(3):1063–1078.
   PubMed Web of Science ®Google Scholar
• Das PJ, Paul P, Mukherjee B, et al. Pulmonary delivery of voriconazole loaded nanoparticles providing a prolonged drug level in lungs: a promise for treating fungal infection. Mol Pharm. 2015;12(8):2651–2664.
   PubMed Web of Science ®Google Scholar
• Dutta D, Chakraborty A, Mukherjee B, et al. Aptamer-conjugated apigenin nanoparticles to target colorectal carcinoma: a promising safe alternative of colorectal cancer chemotherapy. ACS Appl Bio Mater. 2018;1(5):1538–1556.
   PubMedGoogle Scholar
• Li W, Yalcin M, Bharali DJ, et al. Pharmacokinetics, biodistribution, and anti-angiogenesis efficacy of diamino propane tetraiodothyroacetic acid-conjugated biodegradable polymeric nanoparticle. Sci Rep. 2019;9(1):9006.
   PubMedGoogle Scholar
• Kim HK, Choi YH, Verpoorte R. NMR-based metabolomic analysis of plants. Nat Protoc. 2010;5(3):536–549.
   PubMed Web of Science ®Google Scholar
• Barua A, Choudhury P, Nag N, et al. Xanthone from Swertia chirata exerts chemotherapeutic potential against Colon carcinoma. Curr. Sci. 2022;122(1):47–55.
   Web of Science ®Google Scholar
• BarathManiKanth S, Kalishwaralal K, Sriram M, et al. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnol. 2010;8(1):1–15.
   PubMedGoogle Scholar
• Zeb A, Ullah F. A simple spectrophotometric method for the determination of thiobarbituric acid reactive substances in fried fast foods. J. Anal. Methods Chem. 2016;2016:1–5.
   Web of Science ®Google Scholar
• Pal D, Sur S, Mandal S, et al. Prevention of liver carcinogenesis by amarogentin through modulation of G 1/S cell cycle check point and induction of apoptosis. Carcinogenesis. 2012;33(12):2424–2431.
   PubMed Web of Science ®Google Scholar
• Tian H, Zhang T, Qin S, et al. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. J Hematol Oncol. 2022;15(1):1–40.
   PubMed Web of Science ®Google Scholar
• Hsu PC, Jablons DM, Yang CT, et al. Epidermal growth factor receptor (EGFR) pathway, yes-associated protein (Yap) and the regulation of programmed death-ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC). IJMS. 2019;20(15):3821.
   Google Scholar
• Yao L, Xu S. Force-induced selective dissociation of noncovalent antibody–antigen bonds. J Phys Chem B. 2012;116(33):9944–9948.
   PubMed Web of Science ®Google Scholar
• Jose, A Sebastian. Transferrin-conjugated docetaxel–PLGA nanoparticles for tumor targeting: influence on MCF-7 cell cycle. Polymers. 2019;11(11):1905.
   PubMed Web of Science ®Google Scholar
• Jutten B, Dubois L, Li Y, et al. Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells. Radiother Oncol. 2009;92(3):393–398.
   PubMed Web of Science ®Google Scholar
• Fernández-Urrusuno R, Fattal E, Rodrigues JM, et al. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J Biomed Mater Res. 1996;31(3):401–408.
   PubMed Web of Science ®Google Scholar
• Karra N, Nassar T, Ripin AN, et al. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model. Small. 2013;9(24):4221–4236.
   PubMed Web of Science ®Google Scholar
• Cui XY, Park SH, Park WH. Auranofin inhibits the proliferation of lung cancer cells via necrosis and caspase‑dependent apoptosis. Oncol Rep. 2020;44(6):2715–2724.
   PubMed Web of Science ®Google Scholar
• Wathoni N, Puluhulawa LE, Joni IM, et al. Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer. Drug Deliv. 2022;29(1):2959–2970.
   PubMed Web of Science ®Google Scholar
• Maya S, Kumar LG, Sarmento B, et al. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. Carbohydr Polym. 2013;93(2):661–669.
   PubMed Web of Science ®Google Scholar
• Majumder D, Debnath R, Nath P, et al. Bromelain and Olea europaea (L.) leaf extract mediated alleviation of benzo (a) pyrene induced lung cancer through Nrf2 and NFκB pathway. Environ Sci Pollut Res Int. 2021;28(34):47306–47326.
   PubMed Web of Science ®Google Scholar